Correlation Between Allovir and ADC Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allovir and ADC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allovir and ADC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allovir and ADC Therapeutics SA, you can compare the effects of market volatilities on Allovir and ADC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allovir with a short position of ADC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allovir and ADC Therapeutics.

Diversification Opportunities for Allovir and ADC Therapeutics

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Allovir and ADC is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Allovir and ADC Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADC Therapeutics and Allovir is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allovir are associated (or correlated) with ADC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADC Therapeutics has no effect on the direction of Allovir i.e., Allovir and ADC Therapeutics go up and down completely randomly.

Pair Corralation between Allovir and ADC Therapeutics

Given the investment horizon of 90 days Allovir is expected to under-perform the ADC Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Allovir is 4.22 times less risky than ADC Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The ADC Therapeutics SA is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  293.00  in ADC Therapeutics SA on September 13, 2024 and sell it today you would lose (91.50) from holding ADC Therapeutics SA or give up 31.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Allovir  vs.  ADC Therapeutics SA

 Performance 
       Timeline  
Allovir 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
ADC Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ADC Therapeutics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Allovir and ADC Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allovir and ADC Therapeutics

The main advantage of trading using opposite Allovir and ADC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allovir position performs unexpectedly, ADC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will offset losses from the drop in ADC Therapeutics' long position.
The idea behind Allovir and ADC Therapeutics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum